The TransCatheter Valve and Vessels Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 172 participants.

Also called NCT03424941

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 172 participants (enrolled count) (from the registry)
Sponsor
  • Medtronic Registry lists this organization as a collaborator
Registry
  • NCT NCT03424941
Other papers using this trial's data
  • TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and complex or multivessel coronary disease (TCW): an international, multicentre, prospective, open-label, non-inferiority, randomised controlled trial Lancet (London, England), 2025-12-21 DOI, PubMed 39644913

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Austria, Denmark, France, Germany, Greece, Netherlands, Poland, Portugal, Slovakia, Spain (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03424941. Randomized; no masking; primary purpose treatment. Start 2018-05-31 (actual); primary completion 2024-06-26 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The TransCatheter Valve and Vessels Trial
Acronym
TCW
Condition
Aortic Stenosis
Condition
Multi Vessel Coronary Artery Disease
Condition
TAVI
Condition
Fractional Flow Reserve
Intervention (Device)
FFR-guided PCI and TAVI
Intervention (Device)
CABG and SAVR
Lead sponsor
Maatschap Cardiologie Zwolle (class: other)
Collaborator
Medtronic (class: industry)

Record details

Record id
cardio:ct-nct03424941
Content hash
309a10c518268e8271f8e1a5f6a6961678d049ab76b78d1c9fd5d38562c63b73